Literature DB >> 29238515

Role of therapeutic plasma exchange in the treatment of severe hypertriglyceridemia: an experience.

Shaikh Ahmed Muntajib Wassay1, Farhan Javed Dar2, Asem K Saleh1, Ibrahim Mansoor1.   

Abstract

Hypertriglyceridemia of obesity, the metabolic syndrome, and type II diabetes mellitus are highly prevalent in Saudi Arabia. Severe hypertriglyceridemia is a rare but well known cause of acute pancreatitis. In treatment pancreatic rest, lifestyle changes, and lipid-lowering medications are essential, but the response is slow. Recently the role of therapeutic plasma exchange (TPE) has been stressed for fast and effective management in addition to insulin and heparin infusion. TPE for hypertriglyceridemic pancreatitis resulted in drastic improvements in clinical and laboratory findings and patient outcomes as suggested in our cases. However, this procedure is limited due to its high cost and availability only in specialized hospitals.

Entities:  

Keywords:  hypertriglyceridemia; pancreatitis; plasma exchange

Year:  2017        PMID: 29238515      PMCID: PMC5721969          DOI: 10.1177/2042018817739571

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  12 in total

1.  Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases.

Authors:  Tomoki Furuya; Masafumi Komatsu; Kenichi Takahashi; Naoki Hashimoto; Takahiro Hashizume; Naoki Wajima; Minoru Kubota; Seiji Itoh; Takehiko Soeno; Kozo Suzuki; Keiji Enzan; Shigeki Matsuo
Journal:  Ther Apher       Date:  2002-12

Review 2.  Current knowledge of hypertriglyceridemic pancreatitis.

Authors:  Pedro Valdivielso; Alba Ramírez-Bueno; Nils Ewald
Journal:  Eur J Intern Med       Date:  2014-09-27       Impact factor: 4.487

Review 3.  The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: A systematic review.

Authors:  Benjamin Click; Andrea M Ketchum; Rose Turner; David C Whitcomb; Georgios I Papachristou; Dhiraj Yadav
Journal:  Pancreatology       Date:  2015-03-10       Impact factor: 3.996

Review 4.  Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature.

Authors:  Kiran Joglekar; Ben Brannick; Dipen Kadaria; Amik Sodhi
Journal:  Ther Adv Endocrinol Metab       Date:  2017-02-01       Impact factor: 3.565

5.  Hypertriglyceridemia: Is there a role for prophylactic apheresis? A case report.

Authors:  Ana Rita Francisco; Inês Gonçalves; Fátima Veiga; Mónica Mendes Pedro; Fausto J Pinto; Dulce Brito
Journal:  J Bras Nefrol       Date:  2016 Jul-Sep

6.  American Society for Apheresis guidelines on the use of apheresis in clinical practice: practical, concise, evidence-based recommendations for the apheresis practitioner.

Authors:  Jeffrey L Winters
Journal:  J Clin Apher       Date:  2014-05-30       Impact factor: 2.821

7.  Plasmapheresis in the management of severe hypertriglyceridemia.

Authors:  Gilbert Seda; Jill M Meyer; Dennis E Amundson; Massoud Daheshia
Journal:  Crit Care Nurse       Date:  2013-08       Impact factor: 1.708

8.  Therapeutic plasma exchange for hypertriglyceridemia induced pancreatitis: A rapid and practical approach.

Authors:  Chakri Gavva; Ravindra Sarode; Deepak Agrawal; James Burner
Journal:  Transfus Apher Sci       Date:  2016-02-20       Impact factor: 1.764

Review 9.  Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis.

Authors:  Nils Ewald; Hans-Ulrich Kloer
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

10.  Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report.

Authors:  Deepika Jain; John Zimmerschied
Journal:  ScientificWorldJournal       Date:  2009-11-01
View more
  1 in total

1.  The relationship between triglyceride level and the severity of acute hypertriglyceridemic pancreatitis in Chinese patients.

Authors:  Ya Mei Sun; Feng Gao; Xue Chen; Jie Zhang
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.